Trial Profile
Dipeptidyl Peptidase (DPP) IV Inhibition Facilitates Healing of Chronic Foot Ulcers in Patients With Type 2 Diabetes
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Vildagliptin (Primary)
- Indications Diabetic foot ulcer; Type 2 diabetes mellitus
- Focus Pharmacodynamics; Therapeutic Use
- 04 Jul 2016 Status changed from active, no longer recruiting to completed.
- 18 Nov 2011 New trial record